Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01929408 · ClinicalTrials.gov registry record
Feasibility and Outcomes of Allogeneic HCT Compared to Chemotherapy in Older AML Patients
A clinical trial, sponsored by Fred Hutchinson Cancer Center.
- Completed
- Registry status
- 703
- Enrollment target
NCT01929408 is a clinical trial that has completed, run by Fred Hutchinson Cancer Center. The registered enrollment target is 703 participants.
The verdict
NCT01929408 has completed, sponsored by Fred Hutchinson Cancer Center.
- COMPLETED
- Registry status
- 703 participants
- Enrollment target
Study Summary
The purpose of this study is to compare treatment methods and outcomes of patients diagnosed with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 703 participants |
| Start Date | 2013-07-19 |
| Est. Completion | 2018-12-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01929408
The ClinicalTrials.gov registry entry for NCT01929408 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 703 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fred Hutchinson Cancer Center, which has 483 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01929408 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01929408 about?
NCT01929408 is a clinical study titled "Feasibility and Outcomes of Allogeneic HCT Compared to Chemotherapy in Older AML Patients". The purpose of this study is to compare treatment methods and outcomes of patients diagnosed with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).
What is the current status of trial NCT01929408?
This trial is currently completed. The enrollment target is 703 participants. The study started on 2013-07-19. Estimated completion is 2018-12-04.
Who is sponsoring clinical trial NCT01929408?
This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.